GlassScriptPhysician profile
Ahmad Abdelwahed
NPI 1194981365
$7,864.00
in general payments reported to CMS, 2019-2025
52 companies · $831 in 2025
The $831 reported for 2025 was more than what 75% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,882 · 2020: $1,237 · 2021: $1,237 · 2022: $703 · 2023: $1,115 · 2024: $859 · 2025: $831.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,617 · Education: $188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,617.12 |
| Education | $188.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $973.91 | 2019-2025 | Fasenra, Breztri, Tezspire |
| Glaxosmithkline, LLC. | $827.33 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $583.00 | 2019-2024 | Ofev, Stiolto Respimat |
| Actelion Pharmaceuticals US, INC. | $436.37 | 2019-2025 | Uptravi, Opsumit |
| Grifols USA, LLC | $435.02 | 2019-2025 | Prolastin-C Liquid |
| Intuitive Surgical, INC. | $427.24 | 2021 | |
| United Therapeutics Corporation | $372.75 | 2019-2025 | Tyvaso, Remodulin, Orenitram |
| Mallinckrodt Hospital Products INC. | $364.14 | 2020-2025 | Acthar, Terlivaz |
| Baxter Healthcare | $339.90 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Merck Sharp & Dohme LLC | $290.55 | 2019-2024 | Zerbaxa, Recarbrio, Keytruda |
| Regeneron Healthcare Solutions, INC. | $216.42 | 2019-2025 | Dupixent |
| Insmed, INC. | $211.63 | 2019-2025 | Brinsupri, Arikayce |
| Genzyme Corporation | $204.45 | 2019-2025 | |
| Astellas Pharma US INC | $160.09 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $156.34 | 2019-2021 |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmad Abdelwahed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.